Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM.

Br J Dermatol. 2011 Mar;164(3):602-9. doi: 10.1111/j.1365-2133.2010.10134.x. Epub 2011 Feb 3.

2.

Prevalence and treatment patterns of psoriatic arthritis in the UK.

Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM.

Rheumatology (Oxford). 2013 Mar;52(3):568-75. doi: 10.1093/rheumatology/kes324. Epub 2012 Dec 7.

3.

Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection.

Lo Re V 3rd, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD.

Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):807-14. doi: 10.1002/pds.1784.

4.

Prevalence and treatment of psoriasis in the United Kingdom: a population-based study.

Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ.

Arch Dermatol. 2005 Dec;141(12):1537-41.

PMID:
16365254
5.

Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.

Takeshita J, Wang S, Shin DB, Mehta NN, Kimmel SE, Margolis DJ, Troxel AB, Gelfand JM.

JAMA Dermatol. 2015 Feb;151(2):161-9. doi: 10.1001/jamadermatol.2014.2094.

6.

Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.

Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, Herrinton LJ.

Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):842-9. doi: 10.1002/pds.3447. Epub 2013 May 2.

7.

Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study.

Khalid JM, Globe G, Fox KM, Chau D, Maguire A, Chiou CF.

BMC Dermatol. 2013 Aug 19;13:9. doi: 10.1186/1471-5945-13-9.

8.

Potential misclassification of patients with psoriasis in electronic databases.

Icen M, Crowson CS, McEvoy MT, Gabriel SE, Maradit Kremers H.

J Am Acad Dermatol. 2008 Dec;59(6):981-5. doi: 10.1016/j.jaad.2008.08.034. Epub 2008 Oct 2.

9.

Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom.

Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA.

Pharmacoepidemiol Drug Saf. 2016 Apr;25(4):385-91. doi: 10.1002/pds.3877. Epub 2015 Oct 5.

10.

Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network.

Ogdie A, Alehashemi S, Love TJ, Jiang Y, Haynes K, Hennessy S, Choi H, Gelfand JM.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):918-22. doi: 10.1002/pds.3677. Epub 2014 Jul 5.

11.

Incidence and risk factors for psoriasis in the general population.

Huerta C, Rivero E, Rodríguez LA.

Arch Dermatol. 2007 Dec;143(12):1559-65.

PMID:
18087008
12.

Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study.

Löfvendahl S, Theander E, Svensson Å, Carlsson KS, Englund M, Petersson IF.

PLoS One. 2014 May 29;9(5):e98024. doi: 10.1371/journal.pone.0098024. eCollection 2014.

13.

Accuracy of pneumonia hospital admissions in a primary care electronic medical record database.

Meropol SB, Metlay JP.

Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):659-65. doi: 10.1002/pds.3207. Epub 2012 Feb 28.

14.

Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN).

Ruigómez A, Martín-Merino E, Rodríguez LA.

Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):579-85. doi: 10.1002/pds.1919.

PMID:
20131328
15.

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.

Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM.

BMJ. 2013 Oct 15;347:f5961. doi: 10.1136/bmj.f5961.

16.

Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.

Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):556-62. doi: 10.1038/jid.2011.365. Epub 2011 Nov 24.

17.

Kidney disease in moderate-to-severe psoriasis: a critical appraisal.

Jabbar-Lopez ZK, Weatherhead SC, Reynolds NJ.

Br J Dermatol. 2016 Feb;174(2):267-70. doi: 10.1111/bjd.14302.

PMID:
26871922
18.

Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database.

Martín-Merino E, Fortuny J, Rivero E, García-Rodríguez LA.

Diabetes Care. 2012 Apr;35(4):762-7. doi: 10.2337/dc11-2069. Epub 2012 Feb 22.

19.

The prevalence of psoriatic arthritis in people with psoriasis.

Ibrahim G, Waxman R, Helliwell PS.

Arthritis Rheum. 2009 Oct 15;61(10):1373-8. doi: 10.1002/art.24608.

20.

Psoriasis prevalence among adults in the United States.

Rachakonda TD, Schupp CW, Armstrong AW.

J Am Acad Dermatol. 2014 Mar;70(3):512-6. doi: 10.1016/j.jaad.2013.11.013. Epub 2014 Jan 2.

PMID:
24388724

Supplemental Content

Support Center